- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 1 x YFW: 2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethan-1-amine(Non-covalent)
- 1 x J40: [(2R)-1-[oxidanyl-[(2R,3R,5S,6R)-2,3,5,6-tetrakis(oxidanyl)-4-phosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-3-tetradecanoyloxy-propan-2-yl] (5E,8E)-hexadeca-5,8,11,14-tetraenoate(Non-covalent)
- 2 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Warren, A.L. et al., Structural pharmacology and therapeutic potential of 5-methoxytryptamines. Nature (2024)
- Release Date
- 2024-05-15
- Peptides
- Guanine nucleotide-binding protein G(i) subunit alpha-1: A
Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1: B
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2: C
Soluble cytochrome b562,5-hydroxytryptamine receptor 1A,5-hydroxytryptamine receptor 1A: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
GD
R - Membrane
-
We predict this structure to be a membrane protein.